Sonya James

1.3k total citations
18 papers, 632 citations indexed

About

Sonya James is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Sonya James has authored 18 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Sonya James's work include T-cell and B-cell Immunology (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immune Cell Function and Interaction (7 papers). Sonya James is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Immune Cell Function and Interaction (7 papers). Sonya James collaborates with scholars based in United Kingdom and United States. Sonya James's co-authors include Martin J. Glennie, Ruth R. French, Mark S. Cragg, Stephen A. Beers, H.T. Claude Chan, Aymen Al‐Shamkhani, Alison L. Tutt, Ann L. White, Fernanda Castro and Juliet C. Gray and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Blood.

In The Last Decade

Sonya James

16 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonya James United Kingdom 13 431 214 193 177 53 18 632
Brad Stone United States 13 293 0.7× 80 0.4× 191 1.0× 279 1.6× 48 0.9× 29 700
Thomas C. Manning United States 11 341 0.8× 104 0.5× 198 1.0× 231 1.3× 31 0.6× 16 658
Dilip K. Challa United States 12 206 0.5× 244 1.1× 52 0.3× 204 1.2× 22 0.4× 14 505
Maria Veri Italy 8 202 0.5× 248 1.2× 270 1.4× 220 1.2× 38 0.7× 12 578
Nan Ring United States 7 782 1.8× 107 0.5× 464 2.4× 258 1.5× 58 1.1× 12 1.1k
Heidi H. van Ojik Netherlands 9 322 0.7× 325 1.5× 263 1.4× 245 1.4× 34 0.6× 11 620
Bas van der Woning Belgium 12 259 0.6× 118 0.6× 265 1.4× 272 1.5× 24 0.5× 14 612
Grit Lorenczewski Germany 13 441 1.0× 611 2.9× 746 3.9× 269 1.5× 43 0.8× 17 995
Jinny Kim United Kingdom 6 412 1.0× 139 0.6× 259 1.3× 181 1.0× 39 0.7× 8 640
Laura I. Salazar‐Fontana United States 8 312 0.7× 80 0.4× 93 0.5× 149 0.8× 25 0.5× 10 499

Countries citing papers authored by Sonya James

Since Specialization
Citations

This map shows the geographic impact of Sonya James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonya James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonya James more than expected).

Fields of papers citing papers by Sonya James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonya James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonya James. The network helps show where Sonya James may publish in the future.

Co-authorship network of co-authors of Sonya James

This figure shows the co-authorship network connecting the top 25 collaborators of Sonya James. A scholar is included among the top collaborators of Sonya James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonya James. Sonya James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pontarini, Elena, Andrew Clear, Stefano Bombardieri, et al.. (2025). Autophagy is an upstream mediator of chromatin dynamics in normal and autoimmune germinal center B cells. Journal of Clinical Investigation. 135(13).
2.
Oldham, Robert, Kerry L. Cox, Martin C. Taylor, et al.. (2025). FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs. Clinical & Experimental Immunology. 219(1). 1 indexed citations
3.
Yu, Xiaojie, Christian M. Orr, H.T. Claude Chan, et al.. (2023). Reducing affinity as a strategy to boost immunomodulatory antibody agonism. Nature. 614(7948). 539–547. 71 indexed citations
4.
Roghanian, Ali, Robert Oldham, H.T. Claude Chan, et al.. (2022). FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms. Cell Reports. 40(3). 111099–111099. 16 indexed citations
5.
Easton, Alistair, Martin C. Taylor, Sonya James, et al.. (2022). Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma. iScience. 25(9). 104995–104995. 17 indexed citations
6.
Rowley, Tania F., Robert Oldham, Sonya James, et al.. (2021). On-target IgG hexamerisation driven by a C-terminal IgM tail-piece fusion variant confers augmented complement activation. Communications Biology. 4(1). 1031–1031. 17 indexed citations
7.
Yu, Xiaojie, Sonya James, James H. Felce, et al.. (2021). TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity. Communications Biology. 4(1). 772–772. 35 indexed citations
8.
James, Sonya, et al.. (2021). Activation of GABA(A) receptors inhibits T cell proliferation. PLoS ONE. 16(5). e0251632–e0251632. 29 indexed citations
9.
Easton, Alistair, Tatyana Inzhelevskaya, Sonya James, et al.. (2020). Immune characterization of pre-clinical murine models of neuroblastoma. Scientific Reports. 10(1). 16695–16695. 27 indexed citations
10.
Oldham, Robert, C. Ian Mockridge, Sonya James, et al.. (2020). FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion. Journal for ImmunoTherapy of Cancer. 8(1). e000619–e000619. 12 indexed citations
11.
Chan, H.T. Claude, Christine A. Penfold, Sonya James, et al.. (2016). Anti-CD27 Enhances Lymphoma Immunotherapy through Profound Myeloid Cell Recruitment. Blood. 128(22). 3024–3024. 1 indexed citations
12.
Williams, Emily L., Sonya James, Peter Johnson, et al.. (2013). Immunomodulatory Monoclonal Antibodies Combined with Peptide Vaccination Provide Potent Immunotherapy in an Aggressive Murine Neuroblastoma Model. Clinical Cancer Research. 19(13). 3545–3555. 34 indexed citations
13.
Buchan, Sarah L., Vadim Y. Taraban, Tomasz Ślebioda, et al.. (2011). Death receptor 3 is essential for generating optimal protective CD4+ T-cell immunity against Salmonella. European Journal of Immunology. n/a–n/a.
14.
Taraban, Vadim Y., Tomasz Ślebioda, Jane E. Willoughby, et al.. (2010). Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Mucosal Immunology. 4(2). 186–196. 75 indexed citations
15.
White, Ann L., Alison L. Tutt, Sonya James, et al.. (2010). Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant. Immunology. 131(1). 141–151. 34 indexed citations
16.
Gray, Juliet C., Ruth R. French, Sonya James, et al.. (2008). Optimising anti‐tumour CD8 T‐cell responses using combinations of immunomodulatory antibodies. European Journal of Immunology. 38(9). 2499–2511. 45 indexed citations
17.
Castro, Fernanda, Alison L. Tutt, Ann L. White, et al.. (2008). CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses. European Journal of Immunology. 38(8). 2263–2273. 93 indexed citations
18.
Beers, Stephen A., H.T. Claude Chan, Sonya James, et al.. (2008). Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation. Blood. 112(10). 4170–4177. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brad Stone Breakdown of academic impact, for papers by Thomas C. Manning Breakdown of academic impact, for papers by Dilip K. Challa Breakdown of academic impact, for papers by Maria Veri Breakdown of academic impact, for papers by Nan Ring Breakdown of academic impact, for papers by Heidi H. van Ojik Breakdown of academic impact, for papers by Bas van der Woning Breakdown of academic impact, for papers by Grit Lorenczewski Breakdown of academic impact, for papers by Jinny Kim Breakdown of academic impact, for papers by Laura I. Salazar‐Fontana
Rankless by CCL
2026